|
SESSION IIB: Management of ALL in the upfront and R/R settings
|
|
Moderators: Dr. Reyad Mohsen, Dr. Halima El Omri, Dr. Anas Hamad
|
|
8am - 8.20am
|
Towards an always personalized management of B - ALL
|
Prof. Robin Foa
Professor of Hematology - University of Rome, Italy
|
|
8.20am - 8.40am
|
Update of management of T - ALL
|
Prof. Ali Bazarbachi
American university of Beirut
Lebanon
|
|
8.40am - 8.55am
|
Update in management of Bi-Phenotypic acute leukemia
|
Dr. Honar Cherif
Head of Hematology Section
NCCCR - HMC
Qatar
|
|
8.55am - 9.10am
|
BCL2 inhibitors and leukemias: Biologic impact and therapeutic perspectives
|
Dr. Safaa Al Azawi
Hematology - BMT Dept.
NCCCR - HMC
Qatar
|
|
9.10am - 9.25am
|
Burkitt Lymphoma in adult patients-outcome in NCCCR
|
Dr. Afaf Al Battah
Hematology - BMT Dept.
NCCCR - HMC
Qatar
|
|
9.25am - 9:45am
|
Application of PET CT scan in diagnosis and prognosis of Leukemia
|
Dr. Zsolt Lengyel
Senior consultant - Nuclear Medicine
Clinical Imaging Dept.
NCCCR - HMC
Qatar
|
|
9.45am - 10am
|
Q and A Session
|
|
10.00am - 10.20am
|
Coffee Break
|
|
Moderators: Dr. Sergio Crovella and Dr. Kakil I. Rasul
|
|
10:20am - 10:40am
|
Approach to CART therapy resistance
|
Dr. Marco Ruella
University of Pennsylvania
USA
|
|
10.40am - 11am
|
Precision medicine in hematologic malignancies
|
Dr. Chris Allen
Clinical Scientist
Thermofisher Scientific Lab
Switzerland
|
|
11am - 11.20am
|
Artificial intelligence in hematological cancer diagnosis and prediction
|
Dr. Adel El Omri
Professor of Engineering
Hamad Ben Khalifa University,
Qatar
|
|
11.20am - 11.40am
|
Health economic models in acute leukemia
Objectives
|
Dr. Anas Hamad
Director of Pharmacy
NCCCR-Qatar
|
|
11.40am - 1pm
|
Prayer and Lunch
|
|
SESSION III:
Management of ALL in the region
|
|
Moderators: Dr. Hesham El Sabah, Dr. Ruba Taha, Dr. Amal Gulied
|
|
1pm - 1.20pm
|
Precursor early T- lymphoblastic lymphoma leukemia in adults in Qatar
|
Dr. Dina Soliman
Consultant Hematopathology
Lab and Pathology Dept.
HMC - Qatar
|
|
1.20pm - 1.40pm
|
ALL - Experience of Kuwait Cancer Center
|
Dr. Ahmed Al Huraiji
Kuwait Cancer Center
Kuwait
|
|
1.40pm - 2pm
|
ALL - Experience of Oman
|
Dr. Murthada Al Khabori
Sultan Qaboos University
Oman
|
|
2pm to 2.20pm
|
Comparison of modified BFM protocol with hyperCVAD in AYA Ph-ve ALL: A multicenter analysis-KSA
|
Dr. Hind Salama
Consultant Hematology
National Guards
Riyadh, KSA
|
|
2.20pm - 2.35pm
|
Toxicity to therapy especially to asparaginase in ALL Adult patients treated in NCCCR.
|
Dr. Nancy Kassem
Clinical Pharmacist - NCCCR
Qatar
|
|
2.40pm to 3.15pm
|
Coffee Break
|
|
Moderators: Dr. Kamal Al Aboudi, Dr. Safaa Al Azawi
|
|
3.15pm - 3.30pm
|
Special cases in ALL
A. T-lymphoblastic lymphoma/leukemia with eosinophilia
|
Dr. Sara El Korashi
Hematology - BMT Dept.
NCCCR - HMC
Qatar
|
|
3.30pm - 3.45pm
|
B. Li-Fraumeni Syndrome and ALL
|
Dr. Shehab Fareed
Hematology - BMT Dept.
NCCCR - HMC
Qatar
|
|
3.45pm - 4pm
|
C. Unusual Presentation of mediastinal Lymphoblastic Leukemia-Lymphoma
|
Dr. Omar Ismail
Hematology - BMT Dept.
NCCCR - HMC
Qatar
|
|
4pm - 4.15pm
|
D. CNS involvement in ALL
|
Dr. Dina Mudawi
Hematology - BMT Dept.
NCCCR - HMC
Qatar
|
|
4.15pm - 4.30pm
|
Update on transfusion practices in acute leukemia and management of resistance
|
Dr. Sara Adil
A/Head of Transfusion Medicine
Lab and Pathology Dept
HMC, Qatar
|
|
Moderators: Dr. Shereen Al Azzazi and Dr. Amna Gameil
|
|
4.30pm - 4.45pm
|
Gene suppression in ALL
|
Dr. Nader El-Dweik
Sr. Research Scientist
HMC - Qatar
|
|
4.45pm - 5pm
|
Quality control impact on stem cell transplant
|
Dr. Fabio Figueredo
Director of Stem Cell Lab
NCCCR - HMC, Qatar
|
|
5pm - 5.20pm
|
MRD Diagnostics and monitoring - Hybrid presentation
|
Dr. Nicholas Short
Assistant Professor University of Texas
Department of Leukemia
Md Anderson Cancer Center
Huston, USA
|
|
5.20pm - 5.30pm
|
Q and A Session
|
|
5.30pm
|
Closing Remarks and Ceremony
|
